![1]()
News
Low-dose ketamine controls pain from severe chest injury, while sparing opioid consumption
October 1, 2018
SAN DIEGO – The drug may have a benefit among patients whose Injury Severity Score was greater than 15.
![1]()
News
Palliative care consultations reduce hospital costs
October 1, 2018
Are direct hospital costs for patients with serious illnesses affected by palliative care consultations (PCC)?
![1]()
News
Home telemonitoring for heart failure cuts mortality
September 29, 2018
MUNICH – Large, national German TIM-HF2 trial also shows fewer hospitalizations than with usual care.
![1]()
News
Admission eosinopenia predicted severe CDI outcomes
September 29, 2018
Significant predictors of mortality included having more comorbidities and lower systolic blood pressure at admission.
![1]()
News
Treating cannabinoid hyperemesis syndrome
September 28, 2018
Marijuana use is likely to rise, and with it may arise an increasing incidence of cannabinoid hyperemesis syndrome.
![1]()
News
Point-of-care test for respiratory viruses lowers antibiotic use
September 27, 2018
PARIS – In patients presenting with respiratory infections, a point-of-care test for viral infections has been associated with a reduction in unnecessary admissions and antibiotics, saving resources and improving quality of care.
News
Coagulopathy outbreak underscores danger of synthetic cannabinoids
September 26, 2018
Four patients died after developing spontaneous intracranial bleeding.
News
Atrial fib guidelines may fall short on oral anticoagulation
September 25, 2018
Oral anticoagulation threshold according to CHA2DS2-VASc score varied widely after accounting for varying stroke rates in published studies.
![1]()
News
Five-year follow-up confirms safety of antibiotics for uncomplicated appendicitis
September 25, 2018
Antibiotic therapy offers a feasible alternative to appendectomy for the management of uncomplicated acute appendicitis.
![1]()
News
Signs point to growing abuse of gabapentinoids in the U.S.
September 25, 2018
LAS VEGAS – Several states have made gabapentin a Schedule V controlled substance while others have mandatory reporting of its dispensing and sales to prescription monitoring databases.
